CTB news banner

Breadcrumb

Asset Publisher

High-fat diet proven to fuel prostate cancer progression by imitating a key cancer alteration

What molecular event happens for prostate cancer to progress faster and to be deadlier when patients eat a high-fat diet?

Cellular origins of pediatric brain tumours identified

Research team from the Lady Davis Institute, RI-MUHC and SickKids uses new technologies to “interrogate” tumour cells

Rare respiratory diseases: Combining immunology and respiratory expertise for children and adults

The RI-MUHC is one of eight research centres participating in an NIH-funded project to accelerate the understanding of rare suppurative respiratory diseases and innovate in the field

Dr. I. George Fantus receives Lifetime Achievement Award from Diabetes Canada

Acclaim for a career combining love of science with caring for people

The MUHC teams up with LSU Health New Orleans to advance Usher Syndrome antisense therapy research

Researchers collaborate to treat vision loss linked to Usher thanks to a 1.74 million USD grant from the National Institutes of Health

Celebrating the twentieth anniversary of the GPCR Retreat

Fast-forward to more years of innovative research on G protein-coupled receptors (GPCR) ahead of us!

Pediatric neurologist dedicates her career to leukodystrophies

Geneviève Bernard, MD, FRCPC, is this year’s recipient of the Prix d’excellence – Specialist of the Year award for Region 4

So much to discover: Research in the era of legal cannabis

Interview with Carolyn Baglole, director of the new McGill Research Centre for Cannabis

Sepsis: testing before starting treatment is essential

Timely administration of appropriate antibiotics is essential to prevent death in patients with severe infections. Can healthcare teams “skip” drawing blood for bacterial cultures?

A close look at the progression of cells from normal to tumour

How exactly does a normal cell become a tumour?

Strong criteria for diagnosing sarcopenia

Scientists propose diagnostic tools to identify, and possibly limit, the effects of sarcopenia, a disease that significantly reduces the quality of life of the aging population

Nada Jabado receives reward for outstanding leadership from the Pediatric Chairs of Canada

Revolutionary research findings honoured, as well as passion and compassion in research and patient care

Two awards for a Canadian postdoc at meeting that sets the gold standard of HIV science

RI-MUHC trainee Stéphane Isnard honoured for his research on gut permeability in HIV

Canadian researchers on promising path towards developing flu treatment using lipid target

A team of scientists from the RI-MUHC recently identified a target to “tone down” the hyperactive immunity to influenza infection

Dr. Donald Sheppard honoured at the McGill Alumni Association’s annual Honours and Awards banquet

The David Johnston Faculty & Staff Award recognizes his leadership in research efforts to tackle grand challenges in infections and immunity

Harnessing the body’s power in fight against cancer

Immunotherapy has provided lung cancer patients with real hope of recovery

Team from RI-MUHC and Lunenfeld-Tanenbaum Research Institute “follow a gut feeling” and discover a new stem cell

The human body has a remarkable ability to repair and renew itself. However, as we all know, our regenerative capacity quickly dwindles once we reach adulthood.

The unanticipated early origins of childhood brain cancer

Canadian researchers identify earliest traces of brain cancer long before the disease becomes symptomatic

A medical puzzle solved

With colleagues from the RI-MUHC and McGill University, Dr. Nada Jabado discovered a rare genetic mutation in a pair of patients who are brother and sister.

Anti-TB drugs can increase risk of TB re-infection

Treatment leads to changes in gut microbiota, compromising immunity

See Archive - CTB News